Chemokine expression and leucocyte infiltration in Sjögren's syndrome.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 9714357)

Published in Br J Rheumatol on July 01, 1998

Authors

C Cuello1, P Palladinetti, N Tedla, N Di Girolamo, A R Lloyd, P J McCluskey, D Wakefield

Author Affiliations

1: Inflammation Research Unit, School of Pathology, The University of New South Wales, Sydney, Australia.

Articles by these authors

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med (1993) 4.94

Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science (1993) 4.75

Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med (1993) 4.41

The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry (1990) 4.10

A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med (1990) 3.42

Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology (2001) 2.90

Longitudinal study of outcome of chronic fatigue syndrome. BMJ (1994) 2.73

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med (1994) 2.18

Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust (1990) 2.17

What is myalgic encephalomyelitis? Lancet (1988) 2.17

A controversial consensus--comment on article by Broderick et al. J Intern Med (2011) 2.06

Chemokines: leucocyte recruitment and activation cytokines. Lancet (1997) 2.05

Monoclonal gammopathy: benign or not? Aust N Z J Med (1999) 2.03

Eosinophilia-myalgia syndrome associated with L-tryptophan use. Med J Aust (1990) 2.03

Immunological abnormalities in the chronic fatigue syndrome. Med J Aust (1989) 1.95

Transmission of hepatitis C within Australian prisons. Med J Aust (1999) 1.89

Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A (1994) 1.84

Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol (2011) 1.74

Iowa's National Laboratory for the study of Rural Telemedicine: a description of a work in progress. Bull Med Libr Assoc (1995) 1.62

Delayed acute retinal necrosis after herpetic encephalitis. Br J Ophthalmol (1997) 1.57

Fatigue in selected primary care settings: sociodemographic and psychiatric correlates. Med J Aust (1996) 1.55

The pathogenesis of pterygia. Curr Opin Ophthalmol (1999) 1.55

Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol (1998) 1.54

Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol (2001) 1.53

Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol (2006) 1.53

What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry (2001) 1.51

Tracing the fate of limbal epithelial progenitor cells in the murine cornea. Stem Cells (2015) 1.45

Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res (1996) 1.43

Chronic fatigue syndrome: current perspectives on evaluation and management. Med J Aust (1995) 1.41

Treatment of refractory neurosarcoidosis with TNF-inhibitors: what lies ahead? Intern Med J (2012) 1.40

The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol (1985) 1.39

Red blood cell morphology in chronic fatigue syndrome. Lancet (1989) 1.38

Chemokines in acute anterior uveitis. Curr Eye Res (1997) 1.34

Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. J Immunol (1998) 1.30

Immunological determinants of the outcomes from primary hepatitis C infection. Cell Mol Life Sci (2009) 1.25

Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med (2004) 1.24

In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? J Infect Dis (1998) 1.23

Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. J Viral Hepat (2010) 1.23

Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci (2000) 1.21

Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci (2000) 1.17

Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol (2007) 1.15

Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med (1995) 1.13

Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens (2010) 1.12

Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol (1987) 1.12

Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest (1998) 1.09

Uveitis: aetiology and disease associations in an Australian population. Aust N Z J Ophthalmol (1986) 1.08

Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Pathol (1996) 1.07

Chemokines and serpentines: the molecular biology of chemokine receptors. J Leukoc Biol (1993) 1.07

Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol (1994) 1.06

Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol (1997) 1.06

Screening for prolonged fatigue syndromes: validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol (2000) 1.04

Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res (1996) 1.04

Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol (1998) 1.02

Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Med J Aust (2001) 1.02

Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s. Med J Aust (2000) 1.02

Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun (2002) 1.01

Long-term outcome of gold eyelid weights in patients with facial nerve palsy. Otol Neurotol (2001) 1.01

Immunopathogenesis of hepatitis C virus infection. Immunol Cell Biol (2001) 1.01

Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect Immun (1984) 1.01

Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol (1992) 1.01

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug Alcohol Depend (2010) 1.01

Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene. J Immunol (1994) 1.01

Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol (1998) 1.00

Role and regulation of CXC-chemokines in acute experimental keratitis. Exp Eye Res (2003) 0.99

Expression of TNF-alpha by human plasma cells in chronic inflammation. J Leukoc Biol (1997) 0.98

Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. Br J Psychiatry (1997) 0.98

Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci (2001) 0.98

Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis. Clin Experiment Ophthalmol (2000) 0.97

Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol (1986) 0.97

CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut (2004) 0.96

Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment. Invest Ophthalmol Vis Sci (1999) 0.95

Spectrum of sarcoidosis involving the eye and brain. Aust N Z J Ophthalmol (1997) 0.95

Susac syndrome: microangiopathy of the retina, cochlea and brain. Clin Experiment Ophthalmol (2000) 0.94

Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. J Biol Chem (1994) 0.94

Antibodies to HIV are produced within the central nervous system of all subjects with all categories of HIV infection. Aust N Z J Med (1988) 0.94

Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sjögren syndrome: comparison with tonsillar lymphoid follicles. Ann Rheum Dis (1997) 0.93

Diagnosing pediatric asthma: validating the Easy Breathing Survey. J Pediatr (2001) 0.93

Immunological features of HLA-B27 anterior uveitis. Aust J Ophthalmol (1983) 0.93

Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J Clin Invest (1994) 0.93

Cyclosporin therapy in Mooren's ulcer. Br J Ophthalmol (1987) 0.93

The relationship between fatigue, psychological and immunological variables in acute infectious illness. Aust N Z J Psychiatry (1998) 0.93

Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus. Eye (Lond) (2003) 0.93

Eye injuries in patients with major trauma. J Trauma (1999) 0.92